R. Kaiser

发表

Real-World Efficacy of Nintedanib Plus Docetaxel After Progression on Immune Checkpoint Inhibitors: Results From the Ongoing, Non-interventional VARGADO Study.

J. Atz, C. Grohé, H. Müller-Huesmann, 2022, Clinical oncology (Royal College of Radiologists (Great Britain)).

A phase I, open-label dose-escalation study of continuous treatment with BIBF 1120 in combination with paclitaxel and carboplatin as ﬁ rst-line treatment in patients with advanced non-small-cell lung cancer

D. Camidge, G. Otterson, A. Traynor, 2022 .

A case report of uveitis secondary to dupilumab treatment for atopic dermatitis

J. Silverberg, B. Lockshin, Brian K. Do, 2020, JAAD Case Reports.